Urologix, Inc. reported unaudited earnings results for the second quarter and six months ended December 31, 2014. For the quarter, the company reported sales of $3,079,000 against $3,806,000 a year ago. Operating loss was $134,000 against $892,000 a year ago. Loss before income taxes was $353,000 against $1,069,000 a year ago. Net loss was $357,000 or $0.02 per diluted share against $1,085,000 or $0.05 per diluted share a year ago.

For the six months the company reported sales of $6,100,000 against $7,585,000 a year ago. Operating loss was $375,000 against $2,055,000 a year ago. Loss before income taxes was $785,000 against $2,391,000 a year ago. Net loss was $794,000 or $0.04 per diluted share against $2,419,000 or $0.11 per diluted share a year ago. Net cash used for operating activities was $138,000 against $990,000 a year ago. Purchase of property and equipment was $1,000 against $27,000 a year ago.